LUCENTISÂ® (ranibizumab injection) is an FDA-approved prescription medicine for the treatment of patients with wet age-related macular degeneration
(AMD). It is a breakthrough treatment that can do more than just help you maintain your vision. With LUCENTIS, people with wet AMD may see their vision improve or keep the vision they have.
- Up to 40% of patients had a significant improvement of at least 3 more lines (15 letters) on the eye chart.
- 70% of patients could see at least 1 more letter on the eye chart.
- 95% of patients had their eyesight stay the same (lost fewer than 15 letters or 3 lines).
- Up to 40% of patients achieved vision of 20/40 or better.